top of page

CT26 Syngeneic Model

Rincon Bio offers efficacy studies using the CT26 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Colon
Derivation:
Fibroblastic subclones from NNMU-induced colon carcinoma in BALB/c mice
Mutations:
KRAS
NCI60:
No
Weeks from stratification to termination (average):
2.5

CT26 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the CT26 syngeneic model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page